PharmaCyte Biotech proceeding with GMP production of pancreatic cancer product
PharmaCyte announced it has made further important progress in optimizing the complete manufacturing process, including significant improvement of the growth characteristics of the cells from PharmaCyte’s Master Cell Bank after encapsulation. May 20, 2019